Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease

Arch Neurol. 2001 Oct;58(10):1580-3. doi: 10.1001/archneur.58.10.1580.

Abstract

Background: Immune abnormalities are known to be involved in the pathogenesis of sporadic Parkinson disease.

Objective: To examine whether abnormalities in peripheral lymphocytes exist in Parkinson disease.

Methods: Immune mediators, including CD1a, CD3, CD4, CD8, CD45RO, and Fas (CD95), were examined in peripheral lymphocytes of patients by 3-color flow cytometry.

Results: Patients with Parkinson disease displayed a significantly greater population of circulating CD3+ CD4 bright+ CD8 dull+ lymphocytes than age-matched control subjects (P =.005) and patients with cerebrovascular disease (P =.002). The increase in these cells appeared to continue for at least 17 months. These T cells also expressed CD45RO and Fas, markers for activated T cells, while CD1a, a marker for thymic T cells, was negative, suggesting that these cells are mature T cells with immune activities.

Conclusions: As CD4+ CD8+ T cells are known to increase after some specific viral infections, the continuous increase in CD4 bright+ CD8 dull+ T cells shown here may indicate postinfectious immune abnormalities that are possibly associated with the pathogenesis of this slowly progressive, multifactorial neurodegenerative disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antiparkinson Agents / therapeutic use
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Cells, Cultured
  • Cerebrovascular Disorders / immunology*
  • Cytomegalovirus / isolation & purification
  • Diagnosis, Differential
  • Female
  • Flow Cytometry
  • HIV / isolation & purification
  • Herpesvirus 4, Human / isolation & purification
  • Herpesvirus 6, Human / isolation & purification
  • Humans
  • Immunologic Memory
  • Immunophenotyping
  • Kidney Transplantation / immunology
  • Lymphocyte Count
  • Male
  • Myasthenia Gravis / immunology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / immunology*
  • Reference Values
  • T-Lymphocytes, Cytotoxic / immunology
  • Thymus Gland / immunology

Substances

  • Antiparkinson Agents